Orna Therapeutics, Vertex Pharma Enter Three-year Research Collaboration - Quick Facts
Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex ...
Bernstein Remains a Hold on Vertex Pharmaceuticals (VRTX)
Bernstein analyst William Pickering maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target of ...
Zacks.com on MSN14h
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note
Vertex Pharmaceuticals (VRTX) ended the recent trading session at $402.49, demonstrating a -1.13% swing from the preceding day's closing price. This change lagged the S&P 500's daily gain of 0.55%. On ...
Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
The stock's fall snapped a three-day winning streak.
International Business Machines (NYSE:IBM) Stock Price Up 0.5% Following Analyst Upgrade
International Business Machines Co. (NYSE:IBM – Get Free Report)’s stock price traded up 0.5% during mid-day trading on ...
10 stocks making best use of investors’ money. Here’s who beats Nvidia.
A company’s return on average assets sheds light on how well its management team has allocated investors’ money.